Axitinib-13C-d3
|
|
- $605 - $1151
- Product name: Axitinib-13C-d3
- CAS: 1261432-00-1
- MF:
- MW: 0
- EINECS:
- MDL Number:MFCD32858131
- Synonyms:Axitinib-13C-d3;[13C,2H3]-Axitinib;(E)-N-(methyl-13C-d3)-2-((3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)thio)benzamide
2 prices
Selected condition：
Brand
- Cayman Chemical
Package
- 500μg
- 1mg
- ManufacturerCayman Chemical
- Product number26676
- Product descriptionAxitinib-13C-d3
- Packaging500μg
- Price$605
- Updated2024-03-01
- Buy
- ManufacturerCayman Chemical
- Product number26676
- Product descriptionAxitinib-13C-d3
- Packaging1mg
- Price$1151
- Updated2024-03-01
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Cayman Chemical | 26676 | Axitinib-13C-d3 | 500μg | $605 | 2024-03-01 | Buy |
| Cayman Chemical | 26676 | Axitinib-13C-d3 | 1mg | $1151 | 2024-03-01 | Buy |
Properties
storage temp. :Store at -20°C
solubility :DMSO: soluble
form :A solid
color :White to off-white
solubility :DMSO: soluble
form :A solid
color :White to off-white
Safety Information
| Symbol(GHS): |
|
||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal word: | Warning | ||||||||||||||||||||||||||||||
| Hazard statements: |
|
||||||||||||||||||||||||||||||
| Precautionary statements: |
|
Description
Axitinib-13C-d3 is intended for use as an internal standard for the quantification of axitinib by GC- or LC-MS. Axitinib is a VEGFR inhibitor (IC50s = 1.2, 0.25, and 0.29 nM for VEGFR1, -2, and -3, respectively). It also inhibits c-Kit and PDGFRβ (IC50s = 1.7 and 1.6 nM, respectively). It inhibits VEGF-induced migration of and tube formation by human umbilical vein endothelial cells (HUVECs). Axitinib (1-100 mg/kg) reduces microvessel density, a marker of angiogenesis, and tumor growth in MV522 colon carcinoma, A375 melanoma, SN12C-GFP renal carcinoma, and U87 glioma mouse xenograft models in a dose-dependent manner. Formulations containing axitinib have been used in the treatment of renal cell carcinoma.Related product price
- BenzaMide, 2-[(3-iodo-1H-indazol-6-yl)thio]-N-Methyl-
$496.33-1647 - Axitinib Impurity a
$62-345 - 2-(1H-indazol-6-ylthio)-N-Methyl- BenzaMide
$617-653
Suppliers and manufacturers
Zibo Hangyu Biotechnology Development Co., Ltd
Aladdin Scientific
ChemeGen(Shanghai) Biotechnology Co.,Ltd.
Nanjing Shizhou Biology Technology Co.,Ltd
Manhag Testing Technology Co., Ltd
QUALITY CONTROL SOLUTIONS LTD.
Nanjing Shizhou Biology Technology Co.,Ltd
Shanghai Saikerui Biotechnology Co. , Ltd.
Shanghai Yifei Biotechnology Co. , Ltd.
guoyungurui